GFAP and Alexander disease: Given that aberrantly modified GFAP is usually accompanied by a shift in solubility and molecular weight, the HMW GFAP species detected in the RF fractions in human patients and AxD models suggest GFAP could be modified by PTMs potentially involving ubiquitination.